Related Experiment Videos
Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy
1Department of Neurology, University of Kuopio, Finland.
Acta Neurologica Scandinavica. Supplementum
|January 1, 1993
Abstract:
We have studied whether it is possible to discriminate responders to tacrine treatment from patients nonresponsive to tacrine in Alzheimer's disease. The results indicate that mildly demented patients will most likely gain a benefit of tacrine treatment. Neuropsychological tests on attention and working memory after a single dose of tacrine might be useful as well as a single dose pharmaco-EEG in discriminating responders to treatment.